183 related articles for article (PubMed ID: 27195312)
1. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease.
Li W; Liu L; Gomez A; Zhang J; Ramadan A; Zhang Q; Choi SW; Zhang P; Greenson JK; Liu C; Jiang D; Virts E; Kelich SL; Chu HW; Flynn R; Blazar BR; Hanenberg H; Hanash S; Paczesny S
JCI Insight; 2016 May; 1(6):. PubMed ID: 27195312
[TBL] [Abstract][Full Text] [Related]
2. An activated Th17-prone T cell subset involved in chronic graft-versus-host disease sensitive to pharmacological inhibition.
Forcade E; Paz K; Flynn R; Griesenauer B; Amet T; Li W; Liu L; Bakoyannis G; Jiang D; Chu HW; Lobera M; Yang J; Wilkes DS; Du J; Gartlan K; Hill GR; MacDonald KP; Espada EL; Blanco P; Serody JS; Koreth J; Cutler CS; Antin JH; Soiffer RJ; Ritz J; Paczesny S; Blazar BR
JCI Insight; 2017 Jun; 2(12):. PubMed ID: 28614794
[TBL] [Abstract][Full Text] [Related]
3. C-C chemokine receptor 5 and acute graft-versus-host disease.
Yuan J; Ren HY
Immun Inflamm Dis; 2022 Sep; 10(9):e687. PubMed ID: 36039647
[TBL] [Abstract][Full Text] [Related]
4. ICOSL
Adom D; Dillon SR; Yang J; Liu H; Ramadan A; Kushekhar K; Hund S; Albright A; Kirksey M; Adeniyan T; Lewis KE; Evans L; Wu R; Levin SD; Mudri S; Yang J; Rickel E; Seaberg M; Henderson K; Gudgeon CJ; Wolfson MF; Swanson RM; Swiderek KM; Peng SL; Hippen KL; Blazar BR; Paczesny S
Sci Transl Med; 2020 Oct; 12(564):. PubMed ID: 33028709
[TBL] [Abstract][Full Text] [Related]
5. A Pharmacokinetic and Pharmacodynamic Study of Maraviroc as Acute Graft-versus-Host Disease Prophylaxis in Pediatric Allogeneic Stem Cell Transplant Recipients with Nonmalignant Diagnoses.
Khandelwal P; Fukuda T; Mizuno K; Teusink-Cross A; Mehta PA; Marsh RA; Kashuba ADM; Vinks AA; Davies SM
Biol Blood Marrow Transplant; 2016 Oct; 22(10):1829-1835. PubMed ID: 27498124
[TBL] [Abstract][Full Text] [Related]
6. Inducible Costimulator Gene-Transduced Bone Marrow-Derived Mesenchymal Stem Cells Attenuate the Severity of Acute Graft-Versus-Host Disease in Mouse Models.
Yang D; Wang LP; Zhou H; Cheng H; Bao XC; Xu S; Zhang WP; Wang JM
Cell Transplant; 2015; 24(9):1717-31. PubMed ID: 25203502
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. CCR5 ameliorates Japanese encephalitis via dictating the equilibrium of regulatory CD4(+)Foxp3(+) T and IL-17(+)CD4(+) Th17 cells.
Kim JH; Patil AM; Choi JY; Kim SB; Uyangaa E; Hossain FM; Park SY; Lee JH; Eo SK
J Neuroinflammation; 2016 Jul; 13(1):223. PubMed ID: 27439902
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α inhibitor echinomycin reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect.
Yao Y; Wang L; Zhou J; Zhang X
J Transl Med; 2017 Feb; 15(1):28. PubMed ID: 28183349
[TBL] [Abstract][Full Text] [Related]
10. [Chemokine Receptor-5 and Graft-versus-Host Disease].
Yuan J; Liu W; Ren HY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):883-7. PubMed ID: 26117055
[TBL] [Abstract][Full Text] [Related]
11. Post-hematopoietic cell transplantation control of graft-versus-host disease by donor CD425 T cells to allow an effective graft-versus-leukemia response.
Jones SC; Murphy GF; Korngold R
Biol Blood Marrow Transplant; 2003 Apr; 9(4):243-56. PubMed ID: 12720217
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of acute graft-versus-host disease by adoptive transfer of ex vivo expanded human cord blood CD4+CD25+ forkhead box protein 3+ regulatory T cells is associated with the polarization of Treg/Th17 balance in a mouse model.
Yang J; Fan H; Hao J; Ren Y; Chen L; Li G; Xie R; Yang Y; Qian K; Liu M
Transfusion; 2012 Jun; 52(6):1333-47. PubMed ID: 22098312
[TBL] [Abstract][Full Text] [Related]
13. Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantation.
Bahr F; Wehner R; Platzbecker U; Wermke M; Shayegi N; Middeke JM; Röllig C; Schetelig J; Ehninger G; Schmitz M; Bornhäuser M; Tuve S
Biol Blood Marrow Transplant; 2013 Mar; 19(3):357-65. PubMed ID: 23207644
[TBL] [Abstract][Full Text] [Related]
14. Osteopontin attenuates acute gastrointestinal graft-versus-host disease by preventing apoptosis of intestinal epithelial cells.
Kawakami K; Minami N; Matsuura M; Iida T; Toyonaga T; Nagaishi K; Arimura Y; Fujimiya M; Uede T; Nakase H
Biochem Biophys Res Commun; 2017 Apr; 485(2):468-475. PubMed ID: 28192120
[TBL] [Abstract][Full Text] [Related]
15. Alterations in chemokine receptor CCR5 expression on blood dendritic cells correlate with acute graft-versus-host disease.
Shahin K; Sartor M; Hart DN; Bradstock KF
Transplantation; 2013 Oct; 96(8):753-62. PubMed ID: 23903010
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells.
Hilger N; Glaser J; Müller C; Halbich C; Müller A; Schwertassek U; Lehmann J; Ruschpler P; Lange F; Boldt A; Stahl L; Sack U; Oelkrug C; Emmrich F; Fricke S
Cytometry A; 2016 Sep; 89(9):803-15. PubMed ID: 27560708
[TBL] [Abstract][Full Text] [Related]
17. Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.
Murai M; Yoneyama H; Harada A; Yi Z; Vestergaard C; Guo B; Suzuki K; Asakura H; Matsushima K
J Clin Invest; 1999 Jul; 104(1):49-57. PubMed ID: 10393698
[TBL] [Abstract][Full Text] [Related]
18. Graft-vs-leukemia activity and graft-vs-host disease induced by allogeneic Th1- and Th2-type CD4+ T cells in mice.
Zeis M; Uharek L; Hartung G; Glass B; Steinmann J; Schmitz N
Hematol J; 2001; 2(2):136-44. PubMed ID: 11424006
[TBL] [Abstract][Full Text] [Related]
19. Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Radhakrishnan SV; Palaniyandi S; Mueller G; Miklos S; Hager M; Spacenko E; Karlsson FJ; Huber E; Kittan NA; Hildebrandt GC
Biol Blood Marrow Transplant; 2015 Jan; 21(1):30-8. PubMed ID: 25445642
[TBL] [Abstract][Full Text] [Related]
20. CCR5 blockade combined with cyclosporine A attenuates liver GVHD by impairing T cells function.
Tang B; Ren H; Liu H; Shi Y; Liu W; Dong Y; Yin Y; Miao S
Inflamm Res; 2016 Nov; 65(11):917-924. PubMed ID: 27423909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]